Daiichi Sankyo denies 2016 takeover bid by AstraZeneca Ruby Khatun Khatun3 Sept 2017 9:45 AM ISTTOKYO: Japanese drugmaker Daiichi Sankyo denied on Thursday it received a takeover bid last year from Britain’s AstraZeneca, following speculation...
Bristol-Myers, Daiichi Sankyo to test Opdivo combo for cancers Ruby Khatun Khatun3 Sept 2017 9:30 AM ISTBristol-Myers Squibb Co and Daiichi Sankyo said they were evaluating a combination of Bristol-Myers’ immuno-oncology drug, Opdivo, with the Japanese...
Ajanta Pharma launches pain relief tablets in US Ruby Khatun Khatun2 Sept 2017 10:33 AM ISTNew Delhi: Ajanta Pharma on Thursday announced launch of eletriptan hydrobromide tablets, used to treat headaches, in the US market."It is a...
FDA approves new antibacterial drug Vabomere to treat complicated urinary tract infections Ruby Khatun Khatun2 Sept 2017 10:00 AM ISTThe U.S. Food and Drug Administration (FDA) approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney...
Zydus Cadila gets USFDA nod for anti-dementia drug Ruby Khatun Khatun2 Sept 2017 9:49 AM ISTNew Delhi: Drug firm Zydus Cadila on Friday said it has received the final nod from the US health regulator to market Donepezil Hydrochloride tablets...
AstraZeneca aims to offset drug setback at big cancer congress Ruby Khatun Khatun2 Sept 2017 9:30 AM ISTLONDON: After last month’s big clinical trial setback in lung cancer, AstraZeneca will seek to rebuild its oncology reputation next week when it...
Dr Reddys settles patent row with Vivus on weight management drug Ruby Khatun Khatun1 Sept 2017 1:29 PM ISTHyderabad: Nasdaq-listed Vivus Inc on Thursday entered into a settlement agreement with Dr Reddy's Laboratories to resolve a long-pending patent...
Panacea Biotech promoters may demerge real estate business into separate firm Ruby Khatun Khatun1 Sept 2017 1:29 PM ISTNew Delhi: Drug firm Panacea Biotec on Wednesday said its promoters have entered into a family agreement under which they plan to demerge the...
AstraZeneca taps AI for drug discovery in deal with Berg Ruby Khatun Khatun1 Sept 2017 9:45 AM ISTLONDON: AstraZeneca has forged a research collaboration with Boston-based Berg, a specialist in artificial intelligence for drug hunting, in the...
Advertising budget for Obamacare to be cut 90 percent -US health agency Ruby Khatun Khatun1 Sept 2017 9:27 AM ISTWASHINGTON: The U.S. Centers for Medicare and Medicaid Services said on Thursday it plans to spend $10 million on advertising for the upcoming...
Zydus Cadila receives final approval from USFDA for Aspirin and extended release Dipyridamole capsules Ruby Khatun Khatun31 Aug 2017 11:00 AM ISTMumbai: Pharma major, Zydus Cadila said that company received final approval from the US Food and Drug Administration (USFDA) to market Aspirin and...
AstraZeneca strikes 400 million dollar Parkinsons drug deal with Takeda Ruby Khatun Khatun31 Aug 2017 10:30 AM ISTLONDON: AstraZeneca is to receive up to $400 million from Takeda Pharmaceutical after striking a deal for the Japanese company to co-develop an...
